Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Pharmacokinetic Study: Is Three Times Weekly Temocillin Appropriate for the Treatment of Severe Gram-negative Infections in Patients With ESRD Treated With Intermittent Hemodialysis?

NCT02285075 is registered in ClinicalTrials.gov with AZ Sint-Jan AV as lead sponsor.

NCT NCT02285075
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02285075 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Pharmacokinetic Study: Is Three Times Weekly Temocillin Appropriate for the Treatment of Severe Gram-negative Infections in Patients With ESRD Treated With Intermittent Hemodialysis?
Lead sponsor
AZ Sint-Jan AV
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2011
Completion date
December 31, 2014
Enrollment
16 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

gram-negative bacterial infections, renal failure chronic requiring hemodialysis